Bayer updates guidance after Q2 results

• Bayer (OTCPK:BAYRY) Q2 results: (€M): Group Sales: 10,458 (+0.9%), HealthCare: 4,845 (+0.9%), Pharmaceuticals: 4,845 (+0.9%), Consumer Health: 2,960 (+4.6%), CropScience: 2,470 (+3.3%), MaterialScience: 2,864 (-0.4%); Core Net Income: 1,262 (-0.4%); CF Ops: 1,601 (+4.2%).
• 2014 Guidance: Sales growth: 6% from 5%; sales: ~€41B from €41B - 42B; EBITBA (ex. items) growth: low- to mid-single digit; core EPS growth: mid-single-digit.